海外の治験の状況「1」での検索結果
1495件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Recruiting
- A Study to Target the Type I IFN Receptor by Administrating Anifrolumab in RA Patients With a High IFN Signature (TarIFNiRA)
- Rheumatoid Arthritis;Rheumatoid Arthritis;Rheumatoid Arthritis
- Austria
- 2018-01-31
Not Recruiting
- A multicenter, randomized, double-blind, placebo-controlled clinical trial investigating the safety and efficacy of NI-0401 in patients with newly diagnosed Type 1 Diabetes Mellitus (T1D)
- Preservation of beta (ß)-islet cell function in patients newly diagnosed with Type 1 Diabetes MedDRA version: 9.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus
- Austria, Lithuania
- 2009-08-19
Not recruiting
- A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function
- Diabetes;Diabetes Mellitus, Type 1
- Austria, Belgium, Canada, Denmark, Finland, Ireland, Israel, Italy, Norway, Poland, Portugal, Russian Federation, Serbia, Spain, Sweden, Ukraine, United Kingdom, United States
- 2015-05-11
Recruiting
- A PHASE 1/2 DOSE ESCALATION SAFETY, PHARMACOKINETIC AND EFFICACY STUDY OF MULTIPLE INTRAVENOUS ADMINISTRATIONS OF A HUMANIZED MONOCLONAL ANTIBODY (SAR650984) AGAINST CD38 IN PATIENTS WITH SELECTED CD38+ HEMATOLOGICAL MALIGNANCIES
- -C900 Multiple myeloma Multiple myeloma;Multiple myeloma
- Argentina, Austria, Belgium, Brazil, Chile, Colombia, Finland, Greece, Israel, Italy, Mexico, Russian Federation, Spain, Turkey, Ukraine, United Kindgdom, United States
- 2017-02-09
Not recruiting
- The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp
- Diabetes Mellitus, Type 1;Insulin;Retina;Regional Blood Flow
- Austria
- 2008-12-22
Authorised
- Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients with Selected CD38+ Hematological Malignancies
- Haematological malignancy MedDRA version: 20.0 Level: PT Classification code 10066476 Term: Haematological malignancy System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Argentina, Austria, Belgium, Brazil, Chile, Colombia, Finland, Greece, Israel, Italy, Mexico, Peru, Russian Federation, Spain, Turkey, Ukraine, United Kingdom, United States
- 2016-11-04
Not Recruiting
- AN OPEN, MULTI-CENTER, RANDOMIZED, CONTROLLED PILOT TRIAL EVALUATING THE METRONOM CONTINUOUS GLUCOSE MONITORING SYSTEM IN SUBJECTS WITH TYPE 1 DIABETES MELLITUS
- ;E10 - Type 1 diabetes mellitus
- Austria, Canada, Denmark
- 2017-11-28
Authorised
- Phase 2/3 study of rogaratinib (pan FGFR inhibitor) vs chemotherapy in patients with locally advanced or metastatic urothelial carcinoma with a high amount of specific cell growth factor receptors 1 and 3 (FGFR1 and 3) in the tumor cells
- mRNA FGF receptor 1 and 3 positive locally advanced or metastatic urothelial carcinoma progressed after prior platinum-containing chemotherapy MedDRA version: 20.0 Level: LLT Classification code 10064467 Term: Urothelial carcinoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Austria, Belgium, Brazil, Canada, China, Czech Republic, Denmark, Finland, France, Germany, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Democratic People's Republic of, Netherlands, Poland, Portugal, Russian Federation, Singapore, Slovakia, Spain, Sweden, Switzerland, Taiwan, United Kingdom, United States
- 2018-01-18
Not recruiting
- Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes
- Type 1 Diabetes;Type 1 Diabetes;Type 1 Diabetes
- Australia, New Zealand
- 2006-06-12
Not recruiting
- Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1, MMP3, and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma?
- Glaucoma
- Austria
- 2006-04-06